SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Natural Capsules rises on plan to acquire 40% stake in Supreem Pharmaceuticals Mysore

23 Sep 2015 Evaluate

Natural Capsules is currently trading at Rs. 100.00, up by 0.05 points or 0.05% from its previous closing of Rs. 99.95 on the BSE.

The scrip opened at Rs. 100.00 and has touched a high and low of Rs. 100.00 and Rs. 98.10 respectively. So far 600 shares were traded on the counter.

The BSE group 'T ' stock of face value Rs. 10 has touched a 52 week high of Rs. 130.70 on 06-Aug-2015 and a 52 week low of Rs. 58.00 on 21-Oct-2014.

Last one week high and low of the scrip stood at Rs. 102.00 and Rs. 96.35 respectively. The current market cap of the company is Rs. 55.70 crore.

The promoters holding in the company stood at 49.43% while Institutions and Non-Institutions held 0.08% and 50.49% respectively.

Natural Capsules has completed the various documentation (Share purchase agreement, Share Subscription agreement and shareholders agreement) pertaining to the investment of acquiring 40% of equity shares from Supreem Pharmaceuticals Mysore.

The company is in the process of investing the first tranche of investment Rs 5 crore and the balance installment investment of Rs 6.50 crore will be invested on or before March 31, 2016.

Natural Capsules is a well-equipped modern manufacturing plant to manufacture hard gelatin capsule shells, Hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.  

 

 

Natural Capsules Share Price

166.70 1.65 (1.00%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×